| NCCN guidelines insights: management of immunotherapy-related toxicities, version 1.2020: featured updates to the NCCN guidelines JA Thompson, BJ Schneider, J Brahmer, S Andrews, P Armand, S Bhatia, ... Journal of the National Comprehensive Cancer Network 18 (3), 230-241, 2020 | 352 | 2020 |
| Ibrutinib treatment ameliorates murine chronic graft-versus-host disease JA Dubovsky, R Flynn, J Du, BK Harrington, Y Zhong, B Kaffenberger, ... The Journal of clinical investigation 124 (11), 4867-4876, 2014 | 209 | 2014 |
| Management of immunotherapy-related toxicities, version 1.2022, NCCN clinical practice guidelines in oncology JA Thompson, BJ Schneider, J Brahmer, A Achufusi, P Armand, ... Journal of the National Comprehensive Cancer Network 20 (4), 387-405, 2022 | 173 | 2022 |
| Stevens-Johnson syndrome/toxic epidermal necrolysis: a multicenter retrospective study of 377 adult patients from the United States RG Micheletti, Z Chiesa-Fuxench, MH Noe, S Stephen, M Aleshin, ... Journal of Investigative Dermatology 138 (11), 2315-2321, 2018 | 116 | 2018 |
| Single model deep learning on imbalanced small datasets for skin lesion classification P Yao, S Shen, M Xu, P Liu, F Zhang, J Xing, P Shao, B Kaffenberger, ... IEEE transactions on medical imaging 41 (5), 1242-1254, 2021 | 102 | 2021 |
| Development and validation of a risk prediction model for in-hospital mortality among patients with Stevens-Johnson syndrome/toxic epidermal necrolysis—ABCD-10 MH Noe, M Rosenbach, RA Hubbard, A Mostaghimi, AR Cardones, ... JAMA dermatology 155 (4), 448-454, 2019 | 89 | 2019 |
| The effect of climate change on skin disease in North America BH Kaffenberger, D Shetlar, SA Norton, M Rosenbach Journal of the American Academy of Dermatology 76 (1), 140-147, 2017 | 87 | 2017 |
| Estrogen modulation of endosome-associated toll-like receptor 8: an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus NA Young, LC Wu, CJ Burd, AK Friedman, BH Kaffenberger, ... Clinical immunology 151 (1), 66-77, 2014 | 79 | 2014 |
| Cannabinoids for the treatment of chronic pruritus: A review C Avila, S Massick, BH Kaffenberger, SG Kwatra, M Bechtel Journal of the American Academy of Dermatology 82 (5), 1205-1212, 2020 | 77 | 2020 |
| Association of dermatology consultations with patient care outcomes in hospitalized patients with inflammatory skin diseases N Milani-Nejad, M Zhang, BH Kaffenberger JAMA dermatology 153 (6), 523-528, 2017 | 65 | 2017 |
| Trial of anti-BDCA2 antibody litifilimab for cutaneous lupus erythematosus VP Werth, RA Furie, J Romero-Diaz, S Navarra, K Kalunian, ... New England Journal of Medicine 387 (4), 321-331, 2022 | 60 | 2022 |
| Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults L Seminario-Vidal, D Kroshinsky, SJ Malachowski, J Sun, A Markova, ... Journal of the American Academy of Dermatology 82 (6), 1553-1567, 2020 | 60 | 2020 |
| Viral exanthems: An update on laboratory testing of the adult patient AM Korman, A Alikhan, BH Kaffenberger Journal of the American Academy of Dermatology 76 (3), 538-550, 2017 | 51 | 2017 |
| A retrospective descriptive study of oral azole antifungal agents in patients with patch test–negative head and neck predominant atopic dermatitis BH Kaffenberger, J Mathis, MJ Zirwas Journal of the American Academy of Dermatology 71 (3), 480-483, 2014 | 51 | 2014 |
| Improved patient access and outcomes with the integration of an eConsult program (teledermatology) within a large academic medical center RF Wang, J Trinidad, J Lawrence, L Pootrakul, LA Forrest, K Goist, ... Journal of the American Academy of Dermatology 83 (6), 1633-1638, 2020 | 49 | 2020 |
| The role of airborne proteins in atopic dermatitis SG Hostetler, B Kaffenberger, T Hostetler, MJ Zirwas The Journal of clinical and aesthetic dermatology 3 (1), 22, 2010 | 49 | 2010 |
| A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema S Tolliver, J Graham, BH Kaffenberger International Journal of Dermatology 57 (6), 642-645, 2018 | 48 | 2018 |
| Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic J Trinidad, D Kroshinsky, BH Kaffenberger, NW Rojek Journal of the American Academy of Dermatology 83 (1), e69-e71, 2020 | 46 | 2020 |
| Skin diseases associated with Agent Orange and other organochlorine exposures AT Patterson, BH Kaffenberger, RA Keller, DM Elston Journal of the American Academy of Dermatology 74 (1), 143-170, 2016 | 44 | 2016 |
| Dermatologic adverse events associated with selective fibroblast growth factor receptor inhibitors: overview, prevention, and management guidelines ME Lacouture, V Sibaud, MJ Anadkat, B Kaffenberger, J Leventhal, ... The Oncologist 26 (2), e316-e326, 2021 | 42 | 2021 |
